Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Metformin for Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction

NCT03629340 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT03629340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03629340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Metformin for Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Completed
Start date
February 26, 2019
Completion date
February 27, 2026
Enrollment
33 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, pulmonary hypertension